Massive MA fines
November 1, 2010
MEDICINES Australia has fined
its members a total of $560,000 for
breaches in its Code of Conduct
between Jul and Sep this year.
Some companies were fined for
inappropriate media releases
including AstraZeneca ($75,000);
Janssen-Cilag ($15,000); Roche
Products ($30,000) and Sanofiaventis
($20,000).
The lion’s share of fines however
went to Roche Products for its
financial support for medical
practice activities ($200,000); and
its Mircera printed promotional
material, website and dosing card
($200,000).
MEANWHILE Medicines Australia
has also welcomed the changes to
the TGA’s Business Process Reforms
implemented today, which will
reduce the time it takes to evaluate
new medicines for safety, quality
and efficacy by around one year, to
between nine and 11 months.
“Australian patients are the big
winners out of these reforms,” said
Medicines Australia ceo, Dr
Brendan Shaw.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Nov 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Nov 10